Edmond de Rothschild Holding’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Edmond de Rothschild Holding’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$8.76K	–	720
2024 Q1	$8.76K	Hold	1,000	–	–	﹤0.01%	650
2023 Q4	$7.44K	Hold	1,000	–	–	﹤0.01%	663
2023 Q3	$10K	Hold	1,000	–	–	﹤0.01%	663
2023 Q2	$10.3K	Hold	1,000	–	–	﹤0.01%	683
2023 Q1	$10.5K	Hold	1,000	–	–	﹤0.01%	685
2022 Q4	$12.7K	Hold	1,000	–	–	﹤0.01%	735
2022 Q3	$15K	Hold	1,000	–	–	﹤0.01%	758
2022 Q2	$20K	Hold	1,000	–	–	﹤0.01%	731
2022 Q1	$37K	Hold	1,000	–	–	﹤0.01%	705
2021 Q4	$36K	Hold	1,000	–	–	﹤0.01%	732
2021 Q3	$75K	Hold	1,000	–	–	﹤0.01%	656
2021 Q2	$88K	Hold	1,000	–	–	﹤0.01%	623
2021 Q1	$114K	Buy	+1,000	New	+$111K	﹤0.01%	549

Other funds holding CSCI

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Edmond de Rothschild Holding's CSCI Position: Q2 2024 in Review

Edmond de Rothschild Holding sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 1,000 shares — an estimated $8.76K sold.

Edmond de Rothschild Holding first reported a position in CSCI in Q1 2021 and held it in 13 quarters. The position peaked at $114K in Q1 2021. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.

Edmond de Rothschild Holding reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,000 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $8.76K.
Edmond de Rothschild Holding first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2021 and held it in 13 quarters.
Edmond de Rothschild Holding's COSCIENS Biopharma Inc. Common Stock position peaked at $114K in Q1 2021.
13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2024, filed 13 Aug 2024.